Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults

NCT04882085 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Tract Infection
Acute Pyelonephritis
Hospital Acquired Pneumonia
Ventilator-associated Pneumonia
Bacteremia
Intra-abdominal Infection

Interventions

DRUG: Zavicefta, Ceftazidime-Avibactam
DRUG: Best Available Treatment

Sponsor

Pfizer